Clinical Trials Browser

OTHER × Neoplasms, Second Primary × Docetaxel × Clear all

NCT02283424 2014-11-05

Icotinib as the Adjunctive Treatment After Surgery in Stage I-IIIB Lung Adenocarcinoma Patients With EGFR Gene Mutation

Phase 4 Unknown

Neoplasms, Second Primary